Reducing Acute Kidney Injury Occurence by Administering Angiotensin II
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate whether adding angiotensin II to the standard of care is
superior compared to the standard of care alone with respect to kidney damage (personalized
approach) after cardiac surgery.